ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Muscle Biology, Myositis & Myopathies Poster

Date: Sunday, November 8, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM
Abstract Number: 1091
A Computer-Aided Diagnostic System for Quantitative Scoring of Extent of Interstitial Lung Disease (ILD) in Dermatomyositis/Polymyositis Associated ILD
9:00AM-11:00AM
Abstract Number: 1074
A Novel Autoantibody Recognizing a 65-kDa Protein Is Associated with Scleromyositis with Head Drop and/or Bent Spine
9:00AM-11:00AM
Abstract Number: 1090
Abnormal HDL Antioxidant Function Is Associated with Longitudinal Change in Lung Physiology in Dermatomyositis/Polymyositis Associated Lung Disease
9:00AM-11:00AM
Abstract Number: 1083
Alterations of Lipid Profile in IIM Patients Are Associated with Disease Activity, Duration, and Glucocorticoid Treatment
9:00AM-11:00AM
Abstract Number: 1073
Anti Melanoma Differentiation-associated Protein Gene 5 Antibody Titer Monitoring Is a Useful Indicator for Early Detection of Recurrence in Rapidly Progressive Interstitial Lung Disease Associated with Dermatomyositis
9:00AM-11:00AM
Abstract Number: 1098
Anti-cortactin Autoantibodies Are Associated with Key Clinical Features in Adult Myositis but Are Rarely Present in Juvenile Myositis
9:00AM-11:00AM
Abstract Number: 1076
Anti-Jo1 Antibody Quantification Serve as a Prognostic Factor in Anti-synthetase Syndrom
9:00AM-11:00AM
Abstract Number: 1059
Anti-mitochondrial Autoantibodies Are Associated with Cardiomyopathy, Dysphagia, and Features of More Severe Disease in Adult-onset Myositis
9:00AM-11:00AM
Abstract Number: 1064
Anti-SMN Autoantibodies Are Associated with Systemic Sclerosis Small Bowel Involvement in anti-U1RNP Positive Autoimmune Myositis
9:00AM-11:00AM
Abstract Number: 1067
Anti-Viral Proinflammatory Phenotype in Circulating Monocytes from Patients with Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Associated Interstitial Lung Disease
9:00AM-11:00AM
Abstract Number: 1096
Assessing Interstitial Lung Disease in a Racially Diverse Population with Idiopathic Inflammatory Myositis
9:00AM-11:00AM
Abstract Number: 1095
Avascular Necrosis in the Hopkins Myositis Cohort: A Single Center Experience
9:00AM-11:00AM
Abstract Number: 1060
B-cell-rich Inflammatory Myopathies in Adults: Striking Association with Connective Tissue Diseases
9:00AM-11:00AM
Abstract Number: 1071
Characteristics of Anti-Transcription Intermediary Factor 1-gamma Autoantibody Positive Dermatomyositis Patients in Singapore
9:00AM-11:00AM
Abstract Number: 1084
Consumer-based Activity Trackers in Evaluation of Physical Function in Myositis Patients
9:00AM-11:00AM
Abstract Number: 1061
Daily Myositis Symptom Changes Collected via a Smartphone-Based App Are Associated with Flare Occurrence – Providing Evidence of Potential Digital Biomarkers
9:00AM-11:00AM
Abstract Number: 1062
Dermatomyositis: A Dermatology-Rheumatology Clinic Retrospective Analysis
9:00AM-11:00AM
Abstract Number: 1056
Descriptive Data Analysis of Patients with Anti Jo1 Syndrome (AJS) and Lung Involvement
9:00AM-11:00AM
Abstract Number: 1075
Diagnostic Utility of Myositis Antibodies in HyperCKemia: A University Affiliated Single Center Retrospective Study
9:00AM-11:00AM
Abstract Number: 1057
Earlier Cancer Diagnosis After Idiopathic Inflammatory Myopathy Onset Is Associated with Improved Long Term Survival – Results from Four European Cohorts
9:00AM-11:00AM
Abstract Number: 1068
Efficacy of Early Initiation of Plasma Exchange Therapy for a Patient with Anti-MDA5 Autoantibody-Positive Dermatomyositis Developing Refractory Rapidly Progressive Interstitial Lung Disease
9:00AM-11:00AM
Abstract Number: 1077
Glucagon-like Peptide-1 Receptor Agonist Suppresses Muscle Inflammation and Muscle Fiber Death, and Ameliorates Muscle Weakness in Experimental Polymyositis
9:00AM-11:00AM
Abstract Number: 1099
High Burden of Infections in Indian Patients with Idiopathic Inflammatory Myopathy: Validation of Observations from the MyoCite Dataset
9:00AM-11:00AM
Abstract Number: 1078
Highly Reactive anti-Jo1 Autoantibodies to Distinct HisRS Variants and Domains Associate with Lung and Joint Involvement in Patients with Myositis
9:00AM-11:00AM
Abstract Number: 1097
Immunophenotypic Characterization of Myeloid Derived Supressor Cells (MDSCs) and Their Relationship to the Clinical Characteristics of Patients with Inflammatory Myopathies
9:00AM-11:00AM
Abstract Number: 1065
Immunostimulatory Herbal Supplement Use Is More Common Among Patients with Dermatomyositis
9:00AM-11:00AM
Abstract Number: 1093
Impact of Blood Flow Restricted Strength Training on Myogenic Stem Cells and Myofiber Hypertrophy in Sporadic Inclusion Body Myositis Patients
9:00AM-11:00AM
Abstract Number: 1089
Intermuscular Adipose Tissue in Patients with Systemic Lupus Erythematosus
9:00AM-11:00AM
Abstract Number: 1094
Long Term Open Label Extension of Study of Tofacitinib in Refractory Dermatomyositis
9:00AM-11:00AM
Abstract Number: 1092
NMR-Based Serum Metabolomics, Is It Different in Clinico-Serological Clusters of Idiopathic Inflammatory Myositis?
9:00AM-11:00AM
Abstract Number: 1085
Pain in Myositis Is Associated with the Disease Activity
9:00AM-11:00AM
Abstract Number: 1081
Patient-reported Outcomes in Early Autoimmune Inflammatory Myopathies
9:00AM-11:00AM
Abstract Number: 1087
Plasma-derived Extracellular Vesicles Induced STING-mediated Proinflammatory Effects in Dermatomyositis
9:00AM-11:00AM
Abstract Number: 1066
Prevalence of Cervical Dysplasia in Women with Antisynthetase Syndrome
9:00AM-11:00AM
Abstract Number: 1088
Recruitment Rates of Virtual Remote Research (Tele-Research) in Myositis
9:00AM-11:00AM
Abstract Number: 1070
Scleromyositis Is Associated with Distinct Muscle Vasculopathic Features
9:00AM-11:00AM
Abstract Number: 1069
Scleromyositis Is Associated with Nailfold Capillary Abnormalities Compared to Immune-Mediated Necrotizing Myopathy
9:00AM-11:00AM
Abstract Number: 1080
Sensitivity and Specificity of the 2017 EULAR/ACR Criteria for Idiopathic Inflammatory Myopathies in a Cohort of Patients from Latin America
9:00AM-11:00AM
Abstract Number: 1079
Sex Differences in Antibody Profile, Phenotype, and Treatment Response in a Racially Diverse Population with Idiopathic Inflammatory Myopathies
9:00AM-11:00AM
Abstract Number: 1072
Sexual Health Impairment in 62 Female Patients with Idiopathic Inflammatory Myopathies
9:00AM-11:00AM
Abstract Number: 1063
Spirulina Stimulates Inflammatory Cytokine Production Through the STING and TLR Pathways in Dermatomyositis in Vitro
9:00AM-11:00AM
Abstract Number: 1086
The Diagnostic Value and Clinical Significance of Myositis-Specific Antibodies in Patients Suspected to Have Autoimmune Myopathies and/or Autoimmune Rheumatic Diseases
9:00AM-11:00AM
Abstract Number: 1082
The Presence of Anti-Jo1, anti-PL7, And/or anti-MDA5 Antibodies in Idiopathic Inflammatory Myopathy Confers an Increased Risk of a Significant Restrictive Pulmonary Defect
9:00AM-11:00AM
Abstract Number: 1058
The Relationship of Different Muscle Enzymes in Adult Myositis Patients

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology